Ampio Pharmaceuticals appoints interim CFO
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Ampio Pharmaceuticals Inc. opted against renewing the employment agreement of Gregory Gould, its CFO.
The biopharmaceutical company instead tapped its controller, Tom Chilcott, to take over Gould's duties on an interim basis.
Gould had been serving as the CFO of Ampio and Aytu BioScience Inc. since April 2015.